"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Descriptor ID |
D000959
|
MeSH Number(s) |
D27.505.954.411.162
|
Concept/Terms |
Antihypertensive Agents- Antihypertensive Agents
- Agents, Antihypertensive
- Antihypertensives
- Anti-Hypertensives
- Anti Hypertensives
- Antihypertensive Drugs
- Drugs, Antihypertensive
- Anti-Hypertensive Agents
- Agents, Anti-Hypertensive
- Anti Hypertensive Agents
- Anti-Hypertensive Drugs
- Anti Hypertensive Drugs
- Drugs, Anti-Hypertensive
|
Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".
This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
1999 | 2 | 1 | 3 |
2000 | 3 | 0 | 3 |
2001 | 2 | 1 | 3 |
2004 | 1 | 0 | 1 |
2006 | 0 | 2 | 2 |
2008 | 1 | 0 | 1 |
2010 | 1 | 1 | 2 |
2011 | 1 | 0 | 1 |
2012 | 2 | 0 | 2 |
2013 | 0 | 1 | 1 |
2014 | 2 | 1 | 3 |
2015 | 1 | 0 | 1 |
2017 | 1 | 2 | 3 |
2018 | 1 | 0 | 1 |
2020 | 0 | 2 | 2 |
2021 | 1 | 0 | 1 |
2023 | 0 | 5 | 5 |
2024 | 1 | 1 | 2 |
2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.
-
Integrated multi-month dispensing for HIV and hypertension in South Africa: A model of epidemiological impact and cost-effectiveness. J Int AIDS Soc. 2025 Feb; 28(2):e26413.
-
Hypertension guideline implementation and blood pressure control in Matlosana, South Africa. S Afr Fam Pract (2004). 2024 10 30; 66(1):e1-e10.
-
?-blockers are not all the same: pharmacologic similarities and differences, potential combinations and clinical implications. Curr Med Res Opin. 2024; 40(sup1):15-23.
-
Circulating cytokines and risk of developing hypertension: A systematic review and meta-analysis. Pharmacol Res. 2024 Feb; 200:107050.
-
Pregnancy outcomes of women presenting with stage 1 hypertension during the first prenatal clinic visit before 20 gestational weeks. Pregnancy Hypertens. 2024 Mar; 35:19-25.
-
Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis. Adv Ther. 2023 11; 40(11):5076-5089.
-
Detecting and Managing Childhood Onset Hypertension in Africa: A Call to Action. Curr Hypertens Rep. 2023 09; 25(9):211-230.
-
Improvements in Hypertension Control in the Rural Longitudinal HAALSI Cohort of South African Adults Aged 40 and Older, From 2014 to 2019. Am J Hypertens. 2023 05 21; 36(6):324-332.
-
Cost-Effectiveness of Combination Therapy for Patients With Systemic Sclerosis-Related Pulmonary Arterial Hypertension. J Am Heart Assoc. 2021 04 06; 10(7):e015816.
-
Increased Aortic Characteristic Impedance Explains Relations Between Urinary Na+/K+ and Pulse or Systolic Blood Pressure. Hypertension. 2020 05; 75(5):1260-1270.